JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saunders, M. A.
Right arrow Articles by Mitchell, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saunders, M. A.
Right arrow Articles by Mitchell, J. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Vol. 288, Issue 3, 1101-1106, March 1999

Mechanisms of Prostaglandin E2 Release by Intact Cells Expressing Cyclooxygenase-2: Evidence for a `Two-Component' Model1

Michael A. Saunders2, Maria G. Belvisi2 3, Guiseppe Cirino4, P. J. Barnes2, Timothy D. Warner5 and Jane A. Mitchell6

Unit of Critical Care Medicine, Royal Brompton Hospital, Imperial College School of Medicine, National Heart and Lung Institute, London, England

Prostaglandin (PG) release in cells expressing constitutive cyclooxygenase-1 is known to be regulated by liberation of arachidonic acid by phospholipase A2 followed by metabolism by cyclooxygenase. However, the relative contribution of phospholipase A2 to the release of PGs in cells expressing cyclooxygenase-2 is not clear. We addressed this question by using radioimmunoassay to measure PGE2 release by human cells (A549) induced to express cyclooxygenase-2 (measured by Western blot analysis) by interleukin-1beta . Cells were either unstimulated or stimulated with agents known to activate phospholipase A2 (bradykinin, Des-Arg10-kallidin, or the calcium ionophore A23187) or treated with exogenous arachidonic acid. When cells were treated to express cyclooxygenase-2, the levels of PGE2 released over 15 min were undetectable; however, in the same cells stimulated with bradykinin, A23187, or arachidonic acid, large amounts of prostanoid were produced. Using selective inhibitors/antagonists, we found that the effects of bradykinin were mediated by B2 receptor activation and that prostanoid release was due to cyclooxygenase-2, and not cyclooxygenase-1, activity. In addition, we show that the release of PGE2 stimulated by either bradykinin, A23187, or arachidonic acid was inhibited by the phospholipase A2 inhibitor arachidonate trifluoromethyl ketone. Hence, we have demonstrated that PGE2 is released by two components: induction of cyclooxygenase-2 and supply of substrate, probably via activation of phospholipase A2. This is illustrated in A549 cells by a clear synergy between the cytokine interleukin-1beta and the kinin bradykinin.


0022-3565/99/2883-1101$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. Saleh, T. S. Mann, T. Peters, R. J. Betts, and P. J. Henry
Influence of Dexamethasone on Protease-Activated Receptor 2-Mediated Responses in the Airways
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 622 - 630.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. M. Pascual, E. M. Carr, M. C. Seeds, M. Guo, R. A. Panettieri Jr., S. P. Peters, and R. B. Penn
Regulatory features of interleukin-1beta-mediated prostaglandin E2 synthesis in airway smooth muscle
Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L501 - L508.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
F L M Ricciardolo, M C Timmers, J K Sont, G Folkerts, and P J Sterk
Effect of bradykinin on allergen induced increase in exhaled nitric oxide in asthma
Thorax, October 1, 2003; 58(10): 840 - 845.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Grewal, S. Ponnambalam, and J. H. Walker
Association of cPLA2-{alpha} and COX-1 with the Golgi apparatus of A549 human lung epithelial cells
J. Cell Sci., June 1, 2003; 116(11): 2303 - 2310.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. J. BARNES
Endogenous Inhibitory Mechanisms in Asthma
Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): S176 - 181.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.